Kenya's High Court upholds cannabis ban, but tells Nairobi the status quo is no longer tenable

On 15 July 2026, the High Court in Nairobi dismissed a 2021 petition from Kenya's Rastafarian Society that sought to legalise cannabis on grounds of religious freedom, while at the same time telling the Kenyan state, in unusually blunt terms, that the current prohibition regime is "increasingly untenable." The court stopped short of striking down the Narcotic Drugs and Psychotropic Substances Act, leaving the criminal law intact. It opened, instead, a political door that successive administrations in Nairobi have kept shut for decades.

The ruling is a holding action with a built-in expiration date. Kenya's prohibition is preserved, but the bench has, in effect, handed Parliament a written warning that the constitutional questions raised by the Rastafarian challenge will not quietly disappear. The case has always been about more than one religious community's sacrament. It is the most public test yet of whether East Africa's largest economy is willing to treat drug policy as a public-health question rather than a moral one, at a moment when regional neighbours, from South Africa to Lesotho to Zambia, are moving in the opposite direction.

A five-year petition, narrowed to a single right

The Society for the Unification of Rastafari and African Unity, the entity behind the petition, filed the case in 2021 arguing that criminalising cannabis interferes with the free exercise of religion guaranteed under Kenya's constitution. According to Daily Nation's wire on the ruling, the High Court rejected that argument in its entirety, holding that the existing statutory framework does not unconstitutionally burden the petitioners' worship, and that the state retains a legitimate interest in regulating controlled substances.

What makes the judgment noteworthy is what the court said alongside the dismissal. Per The Star Kenya's dispatch from 15 July, the bench urged the country to "begin a national conversation" on cannabis, describing the present arrangement as "increasingly untenable" without specifying which constitutional or empirical threshold Kenya had crossed. The phrasing reads like a textbook example of a court that has run out of patience with legislative inertia and is signalling, through dicta, that the next challenge of equal seriousness will be heard differently.

The Rastafarian community in Kenya, estimated at several thousand members concentrated around Nairobi, Mombasa and parts of the Rift Valley, has long argued that the ban exposes believers to arrest, police harassment and confiscation of a substance they consider sacramental in the same sense that wine is sacramental in Christian liturgy. The petition framed the question narrowly around Article 44 of the constitution, which protects the right to engage in religious practice. The court answered narrowly too, leaving the broader public-health, agricultural and fiscal questions for another forum.

What the prohibition actually looks like on the ground

Kenya's Narcotic Drugs and Psychotropic Substances Act, in force since amendments in the 1990s, criminalises the cultivation, possession, sale and use of cannabis. Penalties range from fines to multi-year prison terms, with stiffer sentences for trafficking-scale offences. The law does not distinguish between personal-use quantities and commercial supply, a feature that has drawn sustained criticism from Kenyan civil-liberty lawyers and from the country's National Authority for the Campaign Against Alcohol and Drug Abuse.

The practical effect is that Kenya's courts process thousands of low-level cannabis cases every year, crowding dockets that also handle more serious narcotics offences involving heroin, methamphetamine and trafficked synthetics. Police statistics cited periodically in Kenyan parliamentary briefs have suggested cannabis accounts for the majority of drug-related arrests, though the exact figure varies by year and reporting jurisdiction. Those numbers matter: they are the empirical ground the High Court appears to be gesturing at when it calls the status quo "increasingly untenable." A legal regime that consumes disproportionate court time while failing visibly to reduce use or harm is, by the standards of any serious policy audit, in need of review.

It is also worth noting what the bench did not do. The court did not order a stay of prosecutions, did not grant a religious exemption to the petitioners, did not refer the matter to the Court of Appeal, and did not invite amicus participation from the Ministry of Health or the National Authority for the Campaign Against Alcohol and Drug Abuse. Each of those moves would have altered the legal landscape immediately. By choosing none of them, the court preserved Parliament's policy space and signalled that any further movement must come legislatively.

The regional drift Kenya is no longer aligned with

The wider African context explains why the High Court's tone is unusually pointed. South Africa has, since 2018, permitted private use and a regulated commercial cannabis sector, and its Western Cape vineyards-turned-cannabis-farms have begun exporting medicinal-grade product to neighbouring markets. Lesotho became the first African country to legalise commercial cultivation in 2017 and has courted international cannabis investment on terms its government framed as economic diversification away from textile exports to the United States. Zambia has moved more cautiously, but has issued licences for medicinal cultivation and export. Uganda has permitted low-THC cultivation for export markets. Even Rwanda, a country not known for regulatory experimentation, has opened a controlled medicinal-cannabis framework.

Kenya sits inside a region where the legal ground has shifted in the last decade, and where the economic case for at least a medicinal and industrial-hemp framework has acquired African champions. The Kenyan argument for standing pat has historically rested on three pillars: the constitution's cautious approach to substance regulation, concern that any liberalisation would compound drug-trafficking exposure on Kenya's Indian Ocean coast, and a cultural and religious conservatism that retains strong purchase across the country's Christian and Muslim communities. None of those pillars has collapsed, and a serious reform debate would have to take each of them seriously rather than dismissing them as window-dressing for inertia.

The counter-argument, which the petitioners did not articulate but which the court appears to be inviting, is that prohibition at the Kenyan scale is no longer producing the outcomes it was written to deliver. A growing medicinal-cannabis export industry in neighbouring states, a permissive regulatory environment in South Africa that Kenyan consumers and patients are already accessing, and a global pharmaceutical market for cannabinoid therapeutics all suggest the costs of standing pat are rising while the benefits are not.

What the court did not decide

The judgment leaves several questions explicitly unresolved, and they will colour what comes next. The court did not adjudicate medicinal cannabis, which is regulated separately under Kenya's pharmacy laws and which is already accessible in narrow therapeutic contexts. It did not address industrial hemp, which falls under agricultural law rather than narcotics law. It did not consider the Rastafarian Society's broader claims about discrimination in policing, which sit in a separate constitutional lane.

What the bench did, instead, is the rarer and arguably more consequential act of telling a sitting Parliament that the constitutional ground on which the present law rests is narrowing. Kenyan courts have shown, historically, that when they speak this way, they expect to be answered within a session or two. The country's drug-policy architecture has not been a serious subject of legislative movement in nearly a decade. The High Court has now placed it firmly back on the agenda, by a route that cannot be ignored and that leaves the prohibition intact for now.

Stakes and what to watch

The political stakes are concrete. A reform effort would touch agriculture (smallholder versus export-oriented hemp cultivation), policing (re-routing enforcement to hard narcotics, which would require retraining and budget reallocation), public health (regulation of potency, packaging, advertising), and tax (a new revenue stream that Kenya's exchequer would have to weigh against harm-mitigation costs). The religious-freedom stakes, raised by the petitioners, remain live. And the international stakes grow as more African jurisdictions move toward regulated frameworks, raising the question of whether Kenya intends to remain a destination market, a transit point, or a producer.

Watch for three signals in the coming weeks. First, whether the Ministry of Health convenes an inter-agency review under the National Authority for the Campaign Against Alcohol and Drug Abuse, the standard incubator for any serious drug-policy work in Nairobi. Second, whether a sponsor emerges in either house of Parliament for a private-member's bill on medicinal or industrial cannabis. Third, whether the petitioners seek leave to appeal to the Court of Appeal, which would test whether the High Court's signals translate into higher-court language that bindingly limits Parliament's options.

This article reflects the two wires available at the time of writing. The High Court's full reasoned judgment had not been published as of publication; specific reasoning paragraphs beyond the reporting summary may differ once the full text is available.

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

• https://t.me/TheStarKenya
• https://t.me/DailyNation